-
@ 41d1479a:9db71bc7
2025-06-15 09:27:46
nostr:nprofile1qy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgr8g2hyzql5lt4cxfjdj40hgtu6vydvsqvsesqy8canygcce3lwvyyapkyy
✍️ Eli Lilly's share price has dropped 6.4% over the past year, but the pharmaceutical company's weight-loss drugs are driving fast revenue and earnings growth.
👉 Eli Lilly's share price has dropped 6.4% over the past year
👉 The company's weight-loss drugs, Mounjaro and Zepbound, are both blockbuster drugs
👉 Demand for the products shows no signs of slowing
👉 Eli Lilly is working on a daily oral treatment for type 2 diabetes and weight loss
👉 The company's growth appears to be sustainable
#LawrenceRothman,CFA #business
nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqy3hwumn8ghj7un9d3shjtt5v4ehgmn9wshxkwrn9ekxz7t9wgejumn9waesqgpey0fwye3ml2fd6f93pttr48gtaemv5pfqgrww7yznyh4xfs0e6sk042ej